electroCore, Inc. Common Stock (ECOR) Stock Price

ECORStock

$7.85+56.37%52W

Market Cap$70.77M

P/E—

PEG Ratio—

Div yield—

Beta1.17

ECOR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)9.94%

Price vs S&P 500 (4W)-33.23%

VGM Score68.84

Book Value / Share (Quarterly)$0.15

P/TBV (Annual)1.95x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)55.07%

Cash Flow / Share (Quarterly)$-1.08

Price vs S&P 500 (YTD)63.10%

Gross Margin (TTM)87.46%

Net Profit Margin (TTM)-39.96%

EPS (TTM)$-1.66

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-1.66

Revenue Growth (5Y)55.71%

EPS (Annual)$-1.65

ROI (Annual)-157.56%

Gross Margin (Annual)87.22%

Net Profit Margin (5Y Avg)-156.44%

Cash / Share (Quarterly)$1.12

Revenue Growth QoQ (YoY)28.03%

ROA (Last FY)-74.82%

Revenue Growth TTM (YoY)33.45%

EBITD / Share (TTM)$-1.53

ROE (5Y Avg)-137.89%

Operating Margin (TTM)-37.64%

Cash Flow / Share (Annual)$-1.03

P/B Ratio63.59x

P/B Ratio (Quarterly)35.20x

Net Income / Employee (Annual)$-168,300

EV / Revenue (TTM)1.87x

Net Interest Coverage (TTM)-46.82x

ROA (TTM)-81.35%

EPS Incl Extra (Annual)$-1.65

Current Ratio (Annual)1.38x

Quick Ratio (Quarterly)0.94x

3-Month Avg Trading Volume0.09M

52-Week Price Return56.37%

Revenue / Employee (TTM)$445,400

Tangible BV / Share (Quarterly)$1.84

P/S Ratio (Annual)2.21x

Asset Turnover (Annual)1.72x

52-Week High$12.70

Operating Margin (5Y Avg)-161.47%

EPS Excl Extra (Annual)$-1.65

Tangible BV CAGR (5Y)-11.91%

26-Week Price Return19.85%

Quick Ratio (Annual)1.11x

13-Week Price Return33.50%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.21x

Enterprise Value$69.04M

Revenue / Share Growth (5Y)22.91%

Asset Turnover (TTM)2.04x

Book Value / Share Growth (5Y)-37.81%

Revenue / Employee (Annual)$385,900

Inventory Turnover (Annual)2.48x

Pretax Margin (Annual)-43.59%

Cash / Share (Annual)$1.45

3-Month Return Std Dev74.56%

Gross Margin (5Y Avg)82.13%

Net Income / Employee (TTM)$-178,000

ROE (Last FY)-157.56%

Net Interest Coverage (Annual)-15.14x

EPS Basic Excl Extra (Annual)$-1.65

Receivables Turnover (TTM)42.93x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.66

Receivables Turnover (Annual)26.76x

ROI (TTM)-235.81%

P/S Ratio (TTM)1.91x

Pretax Margin (5Y Avg)-160.87%

Revenue / Share (Annual)$3.78

Tangible BV / Share (Annual)$3.60

Price vs S&P 500 (52W)40.84%

Year-to-Date Return75.03%

5-Day Price Return-15.41%

EPS Normalized (Annual)$-1.65

ROA (5Y Avg)-75.91%

Net Profit Margin (Annual)-43.60%

Month-to-Date Return-27.45%

Cash Flow / Share (TTM)$-3.91

EBITD / Share (Annual)$-1.49

Operating Margin (Annual)-41.06%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-136.59%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.66

P/TBV (Quarterly)3.02x

P/B Ratio (Annual)14.08x

Inventory Turnover (TTM)2.41x

Pretax Margin (TTM)-40.69%

Book Value / Share (Annual)$1.13

Price vs S&P 500 (13W)30.82%

Beta1.17x

Revenue / Share (TTM)$3.93

ROE (TTM)-235.81%

52-Week Low$4.41

vGradeC

gGradeA

mGradeB

vgmGradeB

ECOR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.42	-$0.33	+21.80%(+$0.09)
Q1 2026	May 6, 2026	-$0.61	-$0.59	+3.67%(+$0.02)
Q4 2025	Mar 19, 2026	-$0.39	-$0.34	+13.38%(+$0.05)
Q3 2025	Nov 5, 2025	-$0.40	-$0.40	+0.00%(+$0.00)
Q2 2025	Aug 6, 2025	-$0.33	-$0.44	-35.38%(-$0.11)

ECOR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.18

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About electroCore, Inc. Common Stock

electroCore Inc develops and commercializes gammaCore, an FDA-cleared non-invasive vagus nerve stimulation device for treating neurological disorders. The platform is approved for the acute and preventive treatment of migraine and cluster headaches in adults, as well as additional headache indications. electroCore is a commercial-stage bioelectronic medicine company leveraging neuromodulation technology in the neurology market.

ECOR Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeAMC

Revenue estimate$10.93M

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

ECOR Insider Transactions

BuySep 14, 2026
ERRICO THOMAS J.
Director
Shares: 5,000Value: $49,082
SellAug 25, 2026
LEV JOSHUA S.
President
Shares: 20,000Value: $200,120
BuyAug 13, 2026
ERRICO THOMAS J.
Director
Shares: 5,000Value: $49,272

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

QTEXQTREX Quantum Ltd. Ordinary SharesSurgical & Medical Instruments
NTRBNutriband Inc. Common StockOrthopedic & Prosthetic Devices
LUNGPulmonx Corporation Common StockSurgical & Medical Instruments
LNSRLENSAR, Inc. Common StockSurgical & Medical Instruments
SKINSkinHealth Systems Inc. Class A Common StockSurgical & Medical Instruments
OPXSOptex Systems Holdings, INCOptical Instruments & Lenses
SPAISafe Pro Group Inc. Common StockOrthopedic & Prosthetic Devices
MBOTMicrobot Medical, Inc. Common StockSurgical & Medical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$4.41

High$12.70